Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 5 de 5 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey AS, Pfeiffer E, Sano M, van Dyck CH, Thal LJ, for the Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379-88. [Ref.ID 74029]
2.Tiene citas relacionadas Cita con resumen
Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Daivs KL, Farlow MR, Jin S, Thomas RG, Thal LJ, for the Alzheimer's Disease Cooperative Study. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression. A randomized controlled trial. JAMA 2003;289:2819-26. [Ref.ID 66501]
3.Tiene citas relacionadas
Aisen PS, Schafer K, Grundman M, Thomas R, Thal LJ. NSAIDs and hypertension. Arch Intern Med 2003;163:1115. [Ref.ID 66282]
4.Tiene citas relacionadas Cita con resumen
Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ, for the Alzheimer's Disease Cooperative Study. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease. JAMA 2000;283:1007-15. [Ref.ID 49519]
5.Tiene citas relacionadas Cita con resumen
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ, for the Members of the Alzheimer's Disease Cooperative Study. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336:1216-22. [Ref.ID 31704]
Seleccionar todas
 
 1 a 5 de 5